Unlike the Donald Trumps of the world, this seems plausible:
Paul Danforth, a former Mets executive who now holds a senior post at CAA Sports, the fast-growing sports division of the Creative Artists Agency of Hollywood, is a lead investor in a group seeking to buy a share of the Mets, according to a person who was briefed on the group’s interest.
He’s affiliated with his father-in-law who happens to be a retired investment banker. The Times reports that at least three other groups have applied to Major League Baseball to see the Mets’ financial statements. All of them are some fun mix of investment banking types, Wall Street types or entrepreneurs.
Danforth may be more serious than others. He worked for the Mets for 13 years in sales and his father-in-law has banking relationships with the Wilpons going back a decade or more. If the Wilpons are going to get someone to buy a minority share and nothing more, it may be more likely to be a friend. At the same time, if they do find it necessary to bake in some sort of option to take over into a minority sale, it may likewise be preferable for them to do so with a friend.
Blue Jays right-hander Marcus Stroman might be headed to the disabled list soon, manager John Gibbons told reporters following Friday’s rain-shortened loss to the Yankees. The righty lasted just four innings on the mound before calling it a night, and gave up five runs, six hits and two walks in a performance that Gibbons claimed was at least partially affected by recurring blister issues on his right middle finger. Now, it looks like he might be removed from the rotation for some much-needed rest and rehabilitation; if so, it’ll be his second such stint this year.
Stroman, 27, has struggled to return the kind of winning record and sub-4.00 ERA that characterized his previous seasons with the club, mostly due to the combined seven weeks he missed with blisters on his throwing hand and chronic fatigue in his right shoulder. In a recent start against the Rays, things got even more gruesome when his blister appeared to start bleeding in the middle of his outing and MLB.com’s Gregor Chisholm notes that the wound has constantly interfered with the right-hander’s pitch selection and delivery. When healthy, Stroman has managed a 4-8 record through 18 starts in 2018 with a career-worst 5.27 ERA, 3.2 BB/9 and 6.8 SO/9 in 100 2/3 innings. This will be the first year since 2015 in which he has not logged at least 200 innings in a single season.
While Stroman may not need an extended stay on the DL before he returns to the mound, it’s not clear what kind of timetable the Blue Jays expect for his recovery. He’s been the second-most valuable starter (behind the now-traded J.A. Happ) in a rotation that currently ranks 17th in the majors with a combined 4.90 ERA and 6.8 fWAR.